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infections in some Brazilians NICUs. Our results reinforce
these ﬁndings and emphasize the importance of early-onset
GBS sepsis considering the high incidence (0.9 cases per 1000
live births) and the fatality rate (50%). Similarly, other authorstreptococcus in a Brazilian  pu
ear Editor,
espite the known efﬁcacy of the intrapartum antibiotic pro-
hylaxis (IAP),1 no Group B Streptococcus (GBS) prophylaxis
rogram are in place in Brazil,2 and rates of early-onset sepsis
EOS) may be underestimated. We conducted a retrospective
nalysis on the incidence EOS, IAP use and outcomes of infants
orn in a Brazilian University Hospital (Hospital de Clínicas
e Uberlândia, HC-U). An early-onset GBS sepsis episode was
eﬁned based on positive blood cultures in the ﬁrst 72 h of
ostnatal life. Blood cultures for all newborn infants with sus-
ected sepsis were performed by an automated system (Vitek
 system BioMerieux, France). Maternal/infant demographic
nd clinical data were obtained from the medical records. The
tudy was approved by the University Hospital Ethics Commit-
ee (protocol 394/09).
From January 2008 to December 2011, there were 8818
ive births. Among them, we identiﬁed eight infants with
onﬁrmed early-onset GBS sepsis. The overall incidence rate
as 0.90 cases per 1000 live births. Infants’ characteristics
nd clinical outcomes are shown in Table 1. All neonates
ere born vaginally. The average hospital length of stay was
ight days (range: 1–36 days). The case-fatality rate was 50%
4/8), occurring in the ﬁrst four days of life. Out of four
Table 1 – Clinical characteristics and outcome of newborns
Case/year Gendera Birth weight (grams) Gestational age (wee
01/2008 M 1450 32 
02/2008 M 3280 37 
03/2009 F 2695 37 
04/2009 M 795 25 
05/2009 F 1520 30 
06/2009 F 1080 28 
07/2009 M 2475 36 
08/2010 F 1545 32 a M, male; F, female.
 Study conducted at the Universidade Federal de Uberlândia (UFU), Mic  hospital
newborns that survived, one had early-onset GBS sepsis asso-
ciated with meningitis and coursed with neurological damage.
We detected one GBS isolate resistant to erythromycin with a
minimum inhibitory concentration of 8 g/ml.
Half of the mothers were ≤16 years old and 75% were
primiparous. Most (75%) had prenatal care. Leukocytosis
(>15,000 cells/mm3) was identiﬁed in two women. One woman
had chorioaminiorrexis >24 h, untreated urinary tract infec-
tion and fever before labor. Another woman had fever (38.6 ◦C)
in the ﬁrst day after delivery and was also diagnosed with uri-
nary tract infection. Although one pregnant woman had been
screened for GBS during pregnancy, the positive GBS  culture
result was not obtained timely. The remaining seven women
were not screened for GBS. Consequently, GBS colonization
status of all pregnant women was unknown at delivery. None
of the mothers received IAP.
Data for newborn infants cared in Brazilian’s NICU show
a high proportion (39.2%) of maternally acquired bloodstream
infections beginning within the ﬁrst 48 h after birth.3 GBS is
referred as the leading etiological agent of maternal acquired
3,4inas Gerais, Brazil.
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have found an overall incidence rate of early-onset GBS sepsis
ranging from 0.39 to 1 per 1000 live births,2,5 with meningi-
tis being detected in a large proportion (26%) of the infected
newborns5 who  had a high (60%) lethality rate.2,5
We  conclude that improvement of prenatal care is rec-
ommended in this population to decrease the burden of
this maternally acquired infectious disease. Implementation
of prophylactic measures should be considered an impor-
tant public health strategy to avoid early-onset GBS sepsis.
The best scenario would be universal culture-based screening
of all pregnant women (35–37 weeks) to identify positive
GBS women who  should receive IAP.1 Furthermore, use of
rapid microbiologic tests could be beneﬁcial for intrapartum
screening in preterm deliveries.
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